Pulmonary Endometriosis Causing Haemoptysis: Report of a Case Treated with Lobectomy

K Kristianen, Knut Ivan Kristiansen, Kristianen K, Fjeld NB, N B Fjeld, Nils B. Fjeld
Scandinavian journal of thoracic and cardiovascular surgery · 1993 · vol. 27(2) , pp. 113–115 · doi:10.3109/14017439309098701 · PMID:8211006 · W2275437447
article OA: closed CC0 ⤵ 30 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This case report describes a 24-year-old woman with catamenial hemoptysis diagnosed with pulmonary endometriosis, treated successfully with lobectomy after medication failed.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A 24-year-old woman with catamenial haemoptysis was treated with the antioestrogenic drug danazol for suspected pulmonary endometriosis. The haemoptysis then ceased, but rapidly recurred when the patient discontinued the medication 3 months later because of severe side effects. Lobectomy was performed, and the diagnosis histologically confirmed, 14 months after the onset of symptoms. Thereafter the patient was free from haemoptysis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hemoptysis Lung Diseases Pneumonectomy Adult Endometriosis Endometriosis Female Hemoptysis Humans Lung Diseases Lung Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (7)

Cited by (30)

Source provenance

europepmc
last seen: 2026-08-07T06:07:27.085738+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:44.647872+00:00
License: CC0 · commercial use OK